Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1990-09-28
1991-08-20
Sneed, Helen M. S.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514178, 514182, 514824, 514176, A61K 3156
Patent
active
050414321
ABSTRACT:
Lanosterols substituted in the 14 and/or 15 position(s) which are active in inhibiting lanosta-8,24-dien-3.beta.-ol 14.alpha.-methyl-demethylase activity, suppressing 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) activity, decreasing cholesterol synthesis and reducing serum cholesterol levels are disclosed.
REFERENCES:
patent: 4202891 (1980-05-01), Schroepfer, Jr. et al.
patent: 4230626 (1980-10-01), Chorvat
Kannel et al., Ann. Intern. Med., 90:85-91 (1979).
Final Report of the Pooling Project, J. Chron. Dis., 31:201-306 (1978).
Brensike et al., Circulation, 69: 313-324 (1984).
Levy et al., Circulation, 69: 325-337 (1984).
Rodwell et al., Adv. Lipid Res., 14: 1-74 (1976).
Brown et al., J. Lipid Res., 21: 505-517 (1980).
Breslow et al., Biochem. Biophys. Acta, 398: 10-17 (1975).
Kandutsch et al., J. Biol. Chem., 252: 409-415 (1977).
Chen et al., J. Biol. Chem., 254: 715-720 (1979).
Kandutsch et al., Science, 201: 498-501 (1978).
Havel et al., J. Biol. Chem., 254: 9573-9582 (1979).
Chang et al., J. Biol. Chem., 255: 7787-7795 (1980).
Gibbons et al., J. Biol. Chem., 255: 395-400, (1980).
Kandutsch et al., J. Biol. Chem., 255: 10813-10821 (1980).
Cavenee et al., J. Biol. Chem., 256: 2675-2681 (1981).
Tanaka et al., J. Biol. Chem., 258: 13331-13339 (1983).
Trzaskos et al., Fed. Proc., 44: 656, (1985).
Schroepfer et al., Proc. Natl. Acad. Sci. USA, 81: 6861-6865.
Batten et al., "The Synthesis of Some 32-Functionalised Lanostane Derivatives", J. Chem. Soc. (cc) 739-748 (1972).
R. B. Woodward et al, "The Synthesis of Lanosterol (Lanostadienol)", J. Chem. Soc., pp. 1131-1144 (1957).
Barton et al., "Conformational Anomalies in Some Triterpenoid Bromoketones" J. Chem. Soc., pp. 2907-2915 (1957).
M. Morisaki "Inhibitory Effect of 15-Oxygenated Sterols on Cholesterol Synthesis from 24,25-Dihydrolanosterol" J. Biochem. vol. 99, pp. 597-600 (1986).
T. J. Bentley et al., "The Synthesis and Configuraton of Some 32-Norlanosterol Derivatives" J.C.S. Perkin I, pp. 749-754 (1972).
L. L. Frye et al., "Novel Inhibitors of Lanosterol 14.alpha.-methyl Demethylase, a Critical Enzyme in Cholesterol Biosynthesis" J. Chem. Soc. Chem. Commun., pp. 129-131 (1988).
Y. Sonoda et al., Chem. Abst. 109: 225w (1988).
E. J. Parish et al. "Sterol Synthesis" J. Lipid Res. vol. 22, pp. 859-868 (1981).
J. M. Trzaskos et al., "Mechanistic Studies of Lanosterol C-32 Demethylation" J. Biol. Chem. vol. 261, pp. 16937-16942 (1986).
M. Anastasia et al., "15-Oxygenated sterols by m-Chloroperbenzoic Acid Oxidation of 3.beta.-Acetoxy-5.alpha.-cholesta-8,14-diene" J. Org. Chem. vol. 46, pp. 3265-3267 (1981).
D. O. Woodward et al., "Purification and Properties of Neurospora Adenylosuccinase" J. Biol. Chem. vol. 241 pp. 580-587 (1966).
A. Shafiee et al., "Oxidative Demethylation of Lanosterol in Cholesterol Biosynthesis: Accumulation of Sterol Intermediates", J. Lipid Res. vol. 27, pp. 1-40 (1986).
M. Anastasia et al. "Synthesis of 11-and 15-Oxygenated Steroids the Course of 8,14-Dienes Oxidation by Chromic Acid" J. Org. Chem. vol. 48, pp. 686-689 (1983).
S. Erickson et al., "7-Ketocholesterol" J. Biol. Chem. vol. 252, pp. 5186-5193 (1977).
J. C. Knight et al. "The Structure of the Cactus Sterol Macdougallin (14.alpha.-Methyl-.DELTA..sup.8 -Cholestene-3.beta.,6.alpha.-diol), A Novel Link in Sterol Biogenesis" J. Am. Chem. Soc. 88:4, pp. 790-798 (1966).
J. C. Knight et al., "The Synthesis of Tritium-Labeled 14.alpha.-Methyl-5.alpha.-cholest-7-en-3.beta.-ol and its Enzymatic Demethylation" J. Biol. Chem. vol. 241, 7 pp. 1502-1508 (1966).
D. A. Leonard et al., "ATP-Dependent Degradation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Permeabilized Cells" J. Biol. Chem. vol. 262, 16 pp. 7914-7919 (1987).
J. Fried, et al. "32-Hydroxylated Lanostane Derivatives by Photolysis of 3.beta.-Acetoxy-7-Ketolanostane" Tetrahedron Letters No. 15, pp. 1677-1680 (1966).
T. J. Bentley, et al., "The Synthesis of 32-Oxygenated Lanostane Derivatives" Tetrahedron Letters, No. 29, pp. 2497-2498 (1965).
Sonoda, et al., "A Simplified Synthesis of 32-Oxygenated Lanosterol Derivatives" Chem. Pharm. Bull. 35 pp. 394-397 (1987).
A. G. Smith et al., "The Sterols of the Echinoderm Asterias rubens", Biochem. J. 135: pp. 443-455 (1973).
C. Tabacik et al., "Post-HMG CoA Reductase Regulation of Cholesterol Biosynthesis in Normal Human Lymphocytes": Lanosten-3.beta.-ol-32-al A Natural Inhibitor, Biochem. Biophys. Res. Commun., 101, pp. 1087-1095 (1981).
Spike, et al, "Structure of a Potential Intermediate in Cholesterol Biosynthesis" J.C.S. Chem. Comm. pp. 477-478 (1974).
Parish, et al., "Synthesis and Structure of 15-Oxygenated 5.alpha.,14.beta.-cholest-7-en-3.beta.-ol Derivatives" Tetrahedron Letters 49, pp. 4401-4404 (1976).
Y. Aoyama et al., "Metabolism of 32-Hydroxy-24,25-dihydrolanosterol by Purified Cytochrome P.sub.14-450DM from Yeast" J. Biochem. 262, pp. 1239-1243 (1987).
G. F. Gibbons et al., "Synthesis and Configuration at C-15 of the Epimeric 5.alpha.-lanost-8-en-3.beta.,15-diols" J.C.S. Chem. Comm. pp. 213-214 (1975).
Gaylor James L.
Johnson Paul R.
Ko Soo S.
Magolda Ronald L.
Stam Simon H.
E. I. Du Pont de Nemours and Company
Saba James
Sneed Helen M. S.
LandOfFree
Steroid derivatives useful as hypocholesterolemics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Steroid derivatives useful as hypocholesterolemics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Steroid derivatives useful as hypocholesterolemics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1008047